Search Orphan Drug Designations and Approvals
-
Generic Name: | Peginterferon alfa-2a |
---|---|
Date Designated: | 07/13/1998 |
Orphan Designation: | Treatment of renal cell carcinoma. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Hoffman-La Roche Inc. 340 Kingsland St. Nutley, New Jersey 07110 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-